Gabriela Godaly
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Targeted innate immune inhibition therapy compared with antibiotics for recurrent acute cystitis: a randomized, open-label phase 2 trial.
Journal: Nature microbiology
Published: October 23, 2025
Engineered phage-derived lysins effectively kill mycobacterial pathogens.
Journal: Trends in biotechnology
Published: September 23, 2025
Antimycobacterial activity of the plectasin derivative NZ2114.
Journal: Frontiers in microbiology
Published: April 17, 2025
Bioinspired mycobacterial lipid coating of porous particles for enhanced antimicrobial efficacy.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: April 03, 2025
Molecular analysis of acute pyelonephritis-excessive innate and attenuated adaptive immunity.
Journal: Life science alliance
Published: July 03, 2024
The role of antibiotic-derived mycobacterial vesicles in tuberculosis pathogenesis.
Journal: Scientific reports
Published: June 11, 2024
Genetic determinants of renal scarring in children with febrile UTI.
Journal: Pediatric nephrology (Berlin, Germany)
Published: February 09, 2024
Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 12, 2023
Isolation and Purification of Mycobacterial Extracellular Vesicles (EVs).
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 31, 2023
Mechanisms of a Mycobacterium tuberculosis Active Peptide.
Journal: Pharmaceutics
Published: January 09, 2023
A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy.
Journal: Scientific reports
Published: July 27, 2020
Last Updated: 09/26/2026